Novo Nordisk
NVO
#16
Rank
NZ$851.60 B
Marketcap
$185.50
Share price
-1.53%
Change (1 day)
18.58%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$71.95 Billion

According to Novo Nordisk's latest financial reports the company's total liabilities are NZ$71.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$48.69 B36.07%
2022-12-31NZ$35.78 B29.72%
2021-12-31NZ$27.58 B47.57%
2020-12-31NZ$18.69 B23.45%
2019-12-31NZ$15.14 B12.5%
2018-12-31NZ$13.46 B12.86%
2017-12-31NZ$11.92 B11.63%
2016-12-31NZ$10.68 B11.31%
2015-12-31NZ$9.59 B25.24%
2014-12-31NZ$7.66 B22.51%
2013-12-31NZ$6.25 B15.93%
2012-12-31NZ$5.39 B-11.28%
2011-12-31NZ$6.08 B7.6%
2010-12-31NZ$5.65 B12.13%
2009-12-31NZ$5.04 B-11.82%
2008-12-31NZ$5.71 B43.7%
2007-12-31NZ$3.97 B8.51%
2006-12-31NZ$3.66 B10.65%
2005-12-31NZ$3.31 B17.98%
2004-12-31NZ$2.80 B17.4%
2003-12-31NZ$2.39 B3.28%
2002-12-31NZ$2.31 B-22.38%
2001-12-31NZ$2.98 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$220.13 B 205.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.30 B 47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$132.63 B 84.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$105.53 B 46.67%๐Ÿ‡ซ๐Ÿ‡ท France